

357. Bull Cancer. 2016 May;103(5):455-60. doi: 10.1016/j.bulcan.2016.02.016. Epub 2016
Apr 13.

[HPV DNA genotyping: A study of anogenital, head and neck and skin cancers in a
population from west Algerian. HPV detection in different cancers from an
Algerian population].

[Article in French]

Nahet A(1), Boublenza L(2), Hassaine H(2), Masdoua N(2), Prétet JL(3), Belglaiaa 
E(4), Mougin C(3).

Author information: 
(1)Université de Tlemcen, laboratoire de microbiologie appliquée à
l'agroalimentaire, au biomédical et à l'environnement (LAMAABE), ex. complexe
biomédical, Imama, bloc C, BP 119, Tlemcen 13000, Algérie. Electronic address:
nahet_amira@hotmail.fr.
(2)Université de Tlemcen, laboratoire de microbiologie appliquée à
l'agroalimentaire, au biomédical et à l'environnement (LAMAABE), ex. complexe
biomédical, Imama, bloc C, BP 119, Tlemcen 13000, Algérie.
(3)Université de Franche-Comté, UBFC, EA3181, LabEx LipSTIC, 25000 Besançon,
France; CHRU de Besançon, laboratoire de biologie cellulaire et moléculaire,
Inserm CIC 1431, 25000 Besançon, France.
(4)Université de Franche-Comté, UBFC, EA3181, LabEx LipSTIC, 25000 Besançon,
France; Université Ibn Zohr, Agadir, Maroc.

OBJECTIVES: To investigate the prevalence of human papillomaviruses (HPV) in
cancers located at different sites in patients from west Algerian and collected
between 2010 and 2014.
MATERIAL AND METHODS: Extracted DNA from archival formaldehyde-fixed and
paraffin-embedded tissues was provided from 39 anogenital cancers, 10 head and
neck cancers and 36 skin cancers. The viral DNA was detected using the INNO-LiPA 
HPV Genotyping Extra(®) kit.
RESULTS: The prevalence of HPV was 100% in cervical cancers, 40% in vaginal
cancers, 17% in vulvar cancers, 33% in anal cancers, 0% in tonsil and larynx
cancers and 6.4% in skin squamous cell carcinoma. In cervical cancers, the most
prevalent genotypes were HPV16 (52%) and HPV18 (12%) as single infection.
CONCLUSION: The overall results agree partially with literature. Extensive
research is necessary to promote HPV vaccine to reduce in particular the burden
of cervical cancer in Algeria.

Copyright © 2016 Société Française du Cancer. Published by Elsevier Masson SAS.
All rights reserved.

DOI: 10.1016/j.bulcan.2016.02.016 
PMID: 27085765  [Indexed for MEDLINE]
